![]() |
市場調査レポート
商品コード
1559461
人工肩関節置換術デバイス - 市場考察、競合情勢、市場予測(2030年)Shoulder Replacement Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
||||||
カスタマイズ可能
適宜更新あり
|
人工肩関節置換術デバイス - 市場考察、競合情勢、市場予測(2030年) |
出版日: 2024年09月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の人工肩関節置換術デバイスの市場規模は、2023年に16億8,000万米ドルであり、2030年までに25億4,000万米ドルに達すると予測され、2024年~2030年の予測期間にCAGRで7.27%の成長が見込まれます。市場は、肩の怪我や変形性関節症や関節リウマチのような退行性疾患の広範な事例、製品開発とイノベーション活動の増加などの要因が市場成長に寄与し、2024年~2030年の予測期間に大きな成長を示しています。
人工肩関節置換術デバイスの市場力学
National Institute of Healthは2022年、肩鎖(AC)関節損傷はスポーツ選手や若年層に顕著に見られ、肩関節損傷の40%超を占めると発表しました。鎖骨と肩甲骨の肩峰が接するAC関節は、肩を安定させる役割と強い衝撃にさらされるため、特に傷つきやすいです。このような損傷は、コンタクトスポーツでよく見られる転倒や衝突などの直接外傷、または反復性のストレスから生じることが多いです。AC関節の損傷は重大な肩の機能障害につながるため、肩関節置換術は患者に快適さを提供するための手術による介入に利用されています。
世界保健機関(WHO)(2023年)によると、世界全体で3億4,400万人が変形性関節症に罹患しています。この人口のうち、変形性関節症患者の73%は55歳超で、60%は女性です。変形性関節症は、肩関節の軟骨の破壊を特徴とする退行性関節疾患で、痛み、こわばり、可動域の減少をもたらします。この疾患はしばしば関節に大きな損傷をもたらし、機能回復と症状緩和に人工肩関節置換術が必要になることがあります。さらに、同じ資料によれば、1,300万人が関節リウマチを患っています。このため、関節の内壁が炎症を起こして侵食され、軟骨や骨の破壊が進行します。人工肩関節置換術(全置換術または部分置換術)は、損傷した関節面を人工のコンポーネントで置換し、機能を回復させ痛みを和らげるために行われます。
規制当局による承認や上市などの製品開発活動の活発化も、人工肩関節置換術デバイスの市場成長に直面する見込みです。例えば2021年7月、Strykerは、肩関節の連続治療におけるギャップを埋める初の生分解性肩峰下バルーンスペーサー、InSpaceのFDA認可を発表しました。このバルーンインプラントは、修復不能な重度の腱板断裂(MIRCT)の関節鏡視下治療に使用される初めての製品でした。InSpaceは、外科医に肩関節治療の新たな選択肢を提供し、患者のニーズにより的確に対応することを可能にしました。
これに加え、2024年5月、人工肩関節インプラントのマーケットリーダーであるShoulder Innovationsは、最新製品であるInSet(TM)95 Humeral Stemの発売を発表しました。InSet(TM)95 Humeral Stemは、骨質が悪い患者の手術成績を向上させ、患者の回復を改善するために設計され、ユニークな2フィンデザインを導入しました。この革新的な特徴は、優れた回転制御と安定性を提供するために特別に設計されたもので、人工肩関節置換術において正確なインプラントのアライメントと最適なバイオメカニクスを可能にします。
したがって、2024年~2030年の予測期間に上記のすべての要因が相互に作用して、肩関節置換術用デバイスの市場を牽引すると予測されます。
しかし、手術中の神経や血管の損傷、人工関節の脱臼などが、人工肩関節置換術デバイス市場の成長を抑制する可能性があります。
人工肩関節置換術デバイス市場のセグメント分析
人工肩関節市場のタイプセグメントでは、解剖学的人工肩関節カテゴリが2023年に最大の市場収益シェアを占めると予測されています。このカテゴリの急成長は、肩関節の自然な構造を再現する能力によるものと考えられます。その主な特徴は、肩関節のボールアンドソケット構造を再構築することで、関節の正常な動きとバイオメカニクスを忠実に再現します。解剖学的人工肩関節には通常、関節窩にフィットする上腕頭コンポーネントが含まれ、よりよいアライメントと安定性を促進します。脱臼リスクの軽減、関節の安定性の向上、術後のリハビリテーションの向上などの利点があります。このアプローチは、変形性関節症や腱板断裂のような、肩本来の機能を可能な限り維持することが重要な疾患を持つ患者にとって特に有益です。
当レポートでは、世界の人工肩関節置換術デバイス市場について調査分析し、各地域の市場規模と予測、過去3年間の製品/技術開発、各セグメントの業績と見通しなどの情報を提供しています。
Shoulder Replacement Devices market by Type (Anatomical Shoulder Prosthesis and Reverse Shoulder Prosthesis), Procedure (Partial Shoulder Arthroplasty, Total Shoulder Arthroplasty, and Revision Shoulder Arthroplasty), Product (Shoulder Arthroplasty Resurfacing Implants, Shoulder Arthroplasty Trauma Devices, and Shoulder Arthroplasty Platform Systems), End-User (Hospitals, Clinics, and Outpatient Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the rising number of road accident cases and sports-related injuries involving the shoulder, and the rising product developmental activities across the globe
The shoulder replacement devices market was valued at USD 1.68 billion in 2023, growing at a CAGR of 7.27% during the forecast period from 2024 to 2030, to reach USD 2.54 billion by 2030. The shoulder replacement devices market is experiencing significant growth owing to the widespread instances of shoulder injuries and degenerative conditions like osteoarthritis and rheumatoid arthritis, the rise in product development & innovation activities, among others that are acting as key factors, contributing to the market growth of the shoulder replacement devices market during the forecast period from 2024 to 2030.
Shoulder Replacement Devices Market Dynamics:
The National Institute of Health in 2022 stated that acromioclavicular (AC) joint injuries are notably prevalent among athletes and young individuals, constituting over 40% of all shoulder injuries. The AC joint, where the clavicle (collarbone) meets the acromion of the scapula (shoulder blade), is particularly vulnerable due to its role in stabilizing the shoulder and its exposure to high-impact forces. These injuries often result from direct trauma, such as falls or collisions common in contact sports, or from repetitive stress. Since AC joint damage leads to significant shoulder dysfunction, shoulder replacement devices are utilized in surgical intervention to provide patient comfort.
According to the World Health Organization (2023), 344 million individuals are affected by osteoarthritis globally. Amongst this population, 73% of people living with osteoarthritis are older than 55 years, and 60% are female. Osteoarthritis is a degenerative joint disease characterized by the breakdown of cartilage in the shoulder joint, leading to pain, stiffness, and reduced range of motion. This condition often results in significant joint damage that may necessitate shoulder replacement surgery to restore function and alleviate symptoms. Moreover, as per the same source, 13 million people are living with rheumatoid arthritis. This causes the joint lining to become inflamed and eroded, leading to progressive destruction of the cartilage and bone. Shoulder replacement surgery, either total or partial, is used to replace the damaged joint surfaces with prosthetic components, restoring function and alleviating pain.
Increased product developmental activities such as approvals by the regulatory bodies and launches are also slated to witness the market growth of shoulder replacement devices. For example, in July 2021, Stryker announced the FDA clearance of the first biodegradable subacromial balloon spacer, InSpace, which filled a gap in the shoulder continuum of care. This balloon implant was the first of its kind for the arthroscopic treatment of massive irreparable rotator cuff tears (MIRCTs). InSpace provided surgeons with a new option in their shoulder continuum of care, enabling them to better address their patients' needs.
In addition to this, in May 2024, Shoulder Innovations, a leader in the shoulder replacement implant market, announced the launch of its latest product, the InSet(TM) 95 Humeral Stem. Designed to enhance surgical outcomes and improve patient recovery for individuals with poor bone quality, the InSet(TM) 95 Humeral Stem introduced a unique 2-fin design. This innovative feature was specifically engineered to provide superior rotational control and stability, allowing for precise implant alignment and optimal biomechanics in shoulder replacement surgery.
Hence, the interplay of all the above mentioned factors are expected to drive the market for shoulder replacement devices market during the given forecast period from 2024 to 2030.
However, nerves & blood vessel damage during surgery, dislocation of artificial joints, and others may restrain the growth of the shoulder replacement devices market.
Shoulder Replacement Devices Market Segment Analysis:
Shoulder Replacement Devices market by Type (Anatomical Shoulder Prosthesis and Reverse Shoulder Prosthesis), Procedure (Partial Shoulder Arthroplasty, Total Shoulder Arthroplasty, and Revision Shoulder Arthroplasty), Product, (Shoulder Arthroplasty Resurfacing Implants, Shoulder Arthroplasty Trauma Devices, and Shoulder Arthroplasty Platform Systems), End-User (Hospitals, Clinics, and Outpatient Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the type segment of the shoulder replacement devices market, the anatomical shoulder prosthesis category of is predicted to account for the largest market revenue share in 2023. The rapid growth of this category can be attributed to its ability to replicate the natural structure of the shoulder joint. A key feature of this is the reconstruction of the ball-and-socket configuration of the shoulder, which closely replicates the normal movement and biomechanics of the joint. The anatomical prosthesis typically includes a humeral head component that fits into a glenoid socket, promoting better alignment and stability. Advantages include reduced risk of dislocation, enhanced joint stability, and improved post-operative rehabilitation. This approach is particularly beneficial for patients with conditions like osteoarthritis or rotator cuff tears, where preserving as much of the natural shoulder function as possible is crucial.
Furthermore, the growing technological advancements in this category by the market key players act as a major factor in boosting its market. For example, In January 2021, Boston Orthopaedic and Spine started offering Equinoxe Stemless Shoulder implant, which is a 3-D printed solution for people who needed shoulder reconstruction surgeries. The product is termed as a bone-conserving prosthesis suited for anatomic shoulder replacement and can deliver long-term fixation to the recipient's bone.
In addition to this, in May 2021, Olympus Corporation of the Americas announced the successful implementation of the 510(k) cleared e-ORTHO Shoulder software, developed by FH ORTHO. This milestone involved an Arrow Prime shoulder replacement procedure, utilizing the advanced e-ORTHO 3D planning software for preoperative surgical technique planning. This innovative software represents a significant advancement in surgical planning technology.
Therefore, the presence of a robust product portfolio for the anatomical shoulder prosthesis category with a wide range of features and applications is expected to witness considerable growth, eventually contributing to the growth of the overall shoulder replacement devices market during the forecast period from 2024 to 2030.
North America is expected to dominate the overall shoulder replacement devices market:
Among all the regions, North America is expected to amass the largest share of the shoulder replacement devices market. This can be ascribed to the increasing instances of shoulder injuries and fractures, the increasing focus on research and development activities, presence of key market players holding high revenue shares in the region, and advanced healthcare infrastructure. Together these factors are driving the need of shoulder replacement devices during the forecast period from 2024 to 2030.
According to the American Academy of Orthopaedic Surgeons (2024), in 2021 more than 100,000 shoulder replacement surgeries are performed annually in the U.S., encompassing total shoulder replacement, hemiarthroplasty, and reverse total shoulder replacement. As per the same source it projects that by 2025, the number of shoulder replacement procedures in the U.S. could range between 174,000 and 350,000.
As per data from the American Academy of Physical Medicine and Rehabilitation (2022), in the US, the incidence of shoulder dislocations is approximately 23.9 per 100,000 person-years, with 85-98% of these being anterior dislocations. The frequency of proximal humerus fractures rises with age, increasing by about 15% per year, and these fractures often become more complex in older individuals. Among those over 65 years old, the incidence of humeral fractures is 101 per 100,000 person-years. Clavicle fractures represent about 2.6% to 10% of all fractures across various sports, with a global incidence ranging from 17.4 to 91 per 100,000 person-years. Acromioclavicular joint separations account for 9-12% of shoulder girdle injuries, with Type I and II separations being the most common. These injuries are predominantly seen in contact sports and occur most frequently in young males aged 20 to 30 years.
Thus, the increasing incidence of shoulder injuries and fractures, coupled with the projected rise in shoulder replacement procedures, underscores the growing demand for shoulder replacement devices, thereby driving significant market growth.
The product developmental activities by the regulatory bodies in the region also push forward the revenue shares of shoulder replacement devices. For example, in 2024, Zimmer Biomet received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ROSA Shoulder System, a robotic assistant designed to aid in shoulder replacement surgeries. This advanced system supports surgeons in performing total shoulder replacements using both anatomic and reverse techniques.
Thus, all the factors mentioned above promote a conducive environment for the shoulder replacement devices market during the forecast period from 2024 to 2030.
Shoulder Replacement Devices Market key players:
Some of the key market players operating in the Shoulder Replacement Devices market include Wright Medical Group, Inc., /Tornier Inc, Integra LifeSciences Corporation, Zimmer Biomet, Johnson & Johnson Services, Inc, Arthrex, Inc, Smith and Nephew Plc, Conmed Corporation, DJO Global, Evolutis, Exactech, Inc, Stryker Corporation, Limacorporate S.p.A., B. Braun Melsungen AG, Elite Surgical, Baumer, and others.
Recent Developmental Activities in the Shoulder Replacement Devices Market:
Key Takeaways from the Shoulder Replacement Devices Market Report Study
Target audience who can be benefited from this Shoulder Replacement Devices Market Report Study
Frequently Asked Questions for the Shoulder Replacement Devices Market:
Shoulder replacement devices are surgical implants used to replace damaged or diseased components of the shoulder joint. They are typically employed in procedures known as shoulder arthroplasty. These devices help restore function and alleviate pain in patients with conditions such as severe arthritis, rotator cuff tears, or fractures.
The shoulder replacement devices market was valued at USD 1.68 billion in 2023, growing at a CAGR of 7.27% during the forecast period from 2024 to 2030, to reach USD 2.54 billion by 2030.
The shoulder replacement devices market is experiencing significant growth, owing to the widespread instances of shoulder injuries and degenerative conditions like osteoarthritis and rheumatoid arthritis, the rise in product development & innovation activities, and among others are acting as key factors is contributing to market growth of the shoulder replacement devices market during the forecast period from 2024 to 2030.
Some of the key market players operating in the shoulder replacement devices market include Wright Medical Group, Inc., /Tornier Inc, Integra LifeSciences Corporation, Zimmer Biomet, Johnson & Johnson Services, Inc, Arthrex, Inc, Smith and Nephew Plc, Conmed Corporation, DJO Global, Evolutis, Exactech, Inc, Stryker Corporation, Limacorporate S.p.A., B. Braun Melsungen AG, Elite Surgical, Baumer, and others.
Among all the regions, North America is estimated to hold a significant revenue share in the shoulder replacement devices market. This can be ascribed to the increasing instances of shoulder injuries and fractures, the increasing focus on research and development activities, presence of key market players holding the high revenue shares in the region and advance healthcare infrastructure. Together these factors are driving the need of shoulder replacement devices during the forecast period from 2024 to 2030.